Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Clin Obstet Gynecol. 2012 Jun;55(2):498-509. doi: 10.1097/GRF.0b013e31824f3b38.

    Prevention of pertussis, tetanus, and diphtheria among pregnant, postpartum women, and infants.

    Source

    Gynecology & Women's Health, University of Louisville, Louisville, Kentucky 40202, USA. sagall@louisville.edu

    Abstract

    Pertussis disease in the United States has been increasing since 1976 and many states are reporting epidemics. Pertussis is more severe in infants less than 3 months of age and is characterized by high hospital admission rates, apnea of the infant. The CDC recommends that Tdap be administered to all pregnant women after the 20th week of gestation to provide pertussis antibodies to the fetus which will offer protection against pertussis disease. Tdap is highly immunogenetic in the pregnant women and has an excellent safety profile. Tdap given to the postpartum patient and her cocoon family is an alternative strategy.

    PMID:
    22510633
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Lippincott Williams & Wilkins

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk